Table 2.

Number of related AEs in patients receiving an effective IdeS dose

System organ class (preferred term)	IdeS 0.12 mg/kg (n = 3)	IdeS 0.25 mg/kg (n = 4)
Vascular disorders
Flushing, n	1
General disorders and administration site conditions
Infusion site pain, n	2
Infections and infestations
Pneumonia, n	1	1
Upper respiratory tract infection, n		1
Influenza, n		1
Nervous system disorders
Headache, n	1	2
Dizziness postural, n		2
Investigations
Alanine aminotransferase increased, n	1	1
Aspartate aminotransferase increased, n	1	2
Alkaline phosphatase, n	1
Musculoskeletal and connective tissue disorders
Myalgia, n		2